MiR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Huang, Songyin ^a   Chen, Yongsong ^b   Wu, Wei ^a   Ouyang, Nengyong ^a   Chen, Jianing ^a   Li, Hongyu ^a   Liu, Xiaoqiang ^a   Su, Fengxi ^a   Lin, Ling ^b   Yao, Yandan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 150; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; TUMOR XENOGRAFT; UPREGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HEK293 CELLS; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RECEPTORS, PURINERGIC P2X7; RNA, NEOPLASM;

EID: 84891611546     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080707     Document Type: Article

References (41)

1. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G (2005) Breast cancer. Lancet 365: 1727-1741.
2. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531.
3. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, et al. (2009) MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 4: e7405.
4. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF (2007) miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A 104: 7080-7085.
5. Wang PY, Li YJ, Zhang S, Li ZL, Yue Z, et al. (2010) Regulating A549 cells growth by ASO inhibiting miRNA expression. Mol Cell Biochem 339: 163-171.
6. Wu Q, Jin H, Yang Z, Luo G, Lu Y, et al. (2010) MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 392: 340-345.
7. Srivastava SK, Bhardwaj A, Singh S, Arora S, Wang B, et al. (2011) MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis 32: 1832-1839.
8. Zhou L, Qi X, Potashkin JA, Abdul-Karim FW, Gorodeski GI (2008) MicroRNAs miR-186 and miR-150 down-regulate expression of the proapoptotic purinergic P2X7 receptor by activation of instability sites at the 39-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 283: 28274-28286.
9. Tano N, Kim HW, Ashraf M (2011) microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4. PLoS One 6: e23114.
10. Gorodeski GI (2009) P2X7-mediated chemoprevention of epithelial cancers. Expert Opin Ther Targets 13: 1313-1332.
11. Ortego M, Bustos C, Hernandez-Presa MA, Tunon J, Diaz C, et al. (1999) Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 147: 253-261.
12. Hughes JP, Hatcher JP, Chessell IP. (2007) The role of P2X(7) in pain and inflammation. Purinergic Signal 3: 163-169.
13. Labrousse VF, Costes L, Aubert A, Darnaudery M, Ferreira G, et al. (2009) Impaired interleukin-1beta and c-Fos expression in the hippocampus is associated with a spatial memory deficit in P2X(7) receptor-deficient mice. PLoS One 4: e6006.
14. Eltom S, Stevenson CS, Rastrick J, Dale N, Raemdonck K, et al. (2011) P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke. PLoS One 6: e24097.
15. Li X, Qi X, Zhou L, Fu W, Abdul-Karim FW, et al. (2009) P2X(7) receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin. Purinergic Signal 5: 351-368.
16. Zhou L, Luo L, Qi X, Li X, Gorodeski GI (2009) Regulation of P2X(7) gene transcription. Purinergic Signal 5: 409-426.
17. Lenertz LY, Wang Z, Guadarrama A, Hill LM, Gavala ML, et al. (2010) Mutation of putative N-linked glycosylation sites on the human nucleotide receptor P2X7 reveals a key residue important for receptor function. Biochemistry 49: 4611-4619.
18. Feng YH, Li X, Wang L, Zhou L, Gorodeski GI (2006) A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J Biol Chem 281: 17228-17237.
19. Barh D, Parida S, Parida B, Viswanathan G (2008) Let-7, miR-125, miR-205, and miR-296 are prospective therapeutic agents in breast cancer molecular medicine. Gene Ther Mol Biol 2008; 12: 189-206.
20. NC D'Amato, H Gu, M Lee, R Heinz, NS Spoelstra, et al. (2012) A functional role for miR-150 in breast cancer. Cancer Res 72(24 Suppl): Abstract nr P5-10-06.
21. Li X, Qi X, Zhou L, Catera D, Rote NS, et al. (2007) Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells. Gynecol Oncol 106: 233-243.
22. Kujoth GC, Leeuwenburgh C, Prolla TA (2006) Mitochondrial DNA mutations and apoptosis in mammalian aging. Cancer Res 66: 7386-7389.
23. Rodriguez-Nieto S, Zhivotovsky B (2006) Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment. Curr Pharm Des 12: 4411-4425.
24. Di Virgilio F, Ferrari D, Adinolfi E (2009) P2X(7): a growth-promoting receptorimplications for cancer. Purinergic Signal 5: 251-256.
25. Weng T, Mishra A, Guo Y, Wang Y, Su L, et al. (2012) Regulation of lung surfactant secretion by microRNA-150. Biochem Biophys Res Commun 422:586-589.
26. Navarro A, Monzo M (2010) MicroRNAs in human embryonic and cancer stem cells. Yonsei Med J 51: 622-632.
27. Navarro A, Marrades RM, Vinolas N, Quera A, Agusti C, et al. (2009) MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis. Oncology 76: 162-169.
28. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, et al. (2010) Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28: 341-347.
29. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, et al. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 1032-1046.
30. Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, et al. (2008) miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol 215: 13-20.
31. Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D (2007) Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 67: 10782-10788.
32. Lu J, Guo S, Ebert BL, Zhang H, Peng X, et al. (2008) MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 14: 843-853.
33. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, et al. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
34. Lin YC, Kuo MW, Yu J, Kuo HH, Lin RJ, et al. (2008) c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. Mol Biol Evol 25: 2189-2198.
35. Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, et al. (2011) The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 25: 1324-1334.
36. Li X, Zhou L, Feng YH, Abdul-Karim FW, Gorodeski GI (2006) The P2X7 receptor: a novel biomarker of uterine epithelial cancers. Cancer Epidemiol Biomarkers Prev 15: 1906-1913.
37. Soti C, Sreedhar AS, Csermely P (2003) Apoptosis, necrosis and cellular senescence: chaperone occupancy as a potential switch. Aging Cell 2: 39-45.
38. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
39. Jeyaseelan K, Herath WB, Armugam A (2007) MicroRNAs as therapeutic targets in human diseases. Expert Opin Ther Targets 11: 1119-1129.
40. Gong C, Yao Y, Wang Y, Liu B, Wu W, et al. (2011) Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem 286: 19127-19137.
41. Sun L, Yao Y, Liu B, Lin Z, Lin L, et al. (2011) MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 31: 432-445.